Charles Woodrow
Overview
Explore the profile of Charles Woodrow including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
636
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Perrone C, Schilling W, Callery J, Ashley E, Chambers M, Chase H, et al.
Wellcome Open Res
. 2023 Mar;
6:216.
PMID: 36866279
The COPCOV study (chloroquine/ hydroxychloroquine prevention of coronavirus disease), which started recruitment in April 2020, is a multi-country double-blind, randomised, placebo-controlled trial which is being conducted in healthcare facilities involved...
2.
3.
Downs L, McNaughton A, de Cesare M, Ansari M, Martin J, Woodrow C, et al.
Wellcome Open Res
. 2021 Feb;
5:240.
PMID: 33458253
Deep sequencing of the full-length hepatitis B virus (HBV) genome provides the opportunity to determine the extent to which viral diversity, genotype, polymorphisms, insertions and deletions may influence presentation and...
4.
Fanello C, Hoglund R, Lee S, Kayembe D, Ndjowo P, Kabedi C, et al.
Antimicrob Agents Chemother
. 2021 Feb;
65(4).
PMID: 33526485
When severe malaria is suspected in children, the WHO recommends pretreatment with a single rectal dose of artesunate before referral to an appropriate facility. This was an individually randomized, open-label,...
5.
Dumbill R, Thompson S, Peschl H, Turner G, Woodrow C
BMJ Case Rep
. 2019 Nov;
12(11).
PMID: 31678919
We describe a case of a 67-year-old man with known chronic obstructive pulmonary disease, type 2 diabetes mellitus, hypertension, osteoarthritis, previous history of excess alcohol intake, and oesophagectomy 3 years...
6.
Intharabut B, Kingston H, Srinamon K, Ashley E, Imwong M, Dhorda M, et al.
J Infect Dis
. 2019 Jan;
219(9):1483-1489.
PMID: 30657916
Background: Artemisinin resistance in falciparum malaria is associated with kelch13 propeller mutations, reduced ring stage parasite killing, and, consequently, slow parasite clearance. We assessed how parasite age affects parasite clearance...
7.
Kingston H, Ghose A, Plewes K, Ishioka H, Leopold S, Maude R, et al.
Open Forum Infect Dis
. 2018 Jan;
4(4):ofx169.
PMID: 29302604
Patients presenting with severe falciparum malaria in a Bangladeshi tertiary hospital had higher total parasite burden, estimated by parasitemia and plasma PfHRP2, than uncomplicated malaria patients despite shorter fever duration....
8.
Mukherjee A, Bopp S, Magistrado P, Wong W, Daniels R, Demas A, et al.
Malar J
. 2017 May;
16(1):195.
PMID: 28494763
Background: Artemisinin resistance is associated with delayed parasite clearance half-life in vivo and correlates with ring-stage survival under dihydroartemisinin in vitro. Both phenotypes are associated with mutations in the PF3D7_1343700...
9.
Miotto O, Amato R, Ashley E, MacInnis B, Almagro-Garcia J, Amaratunga C, et al.
Nat Genet
. 2015 Jan;
47(3):226-34.
PMID: 25599401
We report a large multicenter genome-wide association study of Plasmodium falciparum resistance to artemisinin, the frontline antimalarial drug. Across 15 locations in Southeast Asia, we identified at least 20 mutations...
10.
Simpson J, Jamsen K, Anderson T, Zaloumis S, Nair S, Woodrow C, et al.
PLoS One
. 2013 Jul;
8(7):e69505.
PMID: 23894496
The analysis of in vitro anti-malarial drug susceptibility testing is vulnerable to the effects of different statistical approaches and selection biases. These confounding factors were assessed with respect to pfmdr1...